Back in the 80s, Dr. Gordon sent his first stool tests off to Great Smokies Lab, long before it was Genova Lab. And they have been a source of of great help and great confusion ever since.
In this webinar he sits down with microbiologist Kiran Krishnan to discuss how the keystone species of microbes in the gut are related to chronic illness.
They go over how keystone species can have an anti-inflammatory impact on the body, how they help to regulate pathogenic microbes, and how they can help regulate stress.
Kiran is also offering a complimentary live webinar to sharing strategies to rebuild your microbiome.
Optimize Your Microbiome to Reverse Chronic Symptoms and Regain Your Health
Tuesday, Jan 28th - 4 p.m. PST / 7 p.m. EST
Register now https://xan560.isrefer.com/go/byrg/a62/?utm_source=affiliate
.
If you are interested in learning about what treatment at Gordon Medical could do for your health, schedule a complimentary discovery call here: https://gordonmedical.com/discovery-call/
.
.
📢: ** This information is not to be taken as medical advice. Always consult your practitioner before making any changes to your treatment.
Some of the Studies Mentioned:
An Epidemic of Absence: A New Way of Understanding Allergies and Autoimmune Diseases - Moises Velasquez-Manoff
https://www.amazon.com/Epidemic-Absence-Understanding-Allergies-Autoimmune/dp/1439199396
Tudela H, Claus SP, Saleh M. Next Generation Microbiome Research: Identification of Keystone Species in the Metabolic Regulation of Host-Gut Microbiota Interplay. Front Cell Dev Biol. 2021 Sep 1;
9:719072. doi: 10.3389/fcell.2021.719072. PMID: 34540837; PMCID: PMC8440917.
https://www.frontiersin.org/articles/10.3389/fcell.2021.719072/full
Ziad Al Nabhani, Gérard Eberl, Imprinting of the immune system by the microbiota early in life, Mucosal Immunology, Volume 13, Issue 2, 2020, Pages 183-189, ISSN 1933-0219.
https://doi.org/10.1038/s41385-020-0257-y
Yeoh YK, Zuo T, Lui GC, et al, Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19Gut 2021;7
0:698-706.
https://gut.bmj.com/content/70/4/698
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? A. Elkrief, L. Derosa, G. Kroemer, L. Zitvogel, B. Routy
DOI: https://doi.org/10.1093/annonc/mdz206
Rybak, I.; Haas, K.N.; Dhaliwal, S.K.; Burney, W.A.; Pourang, A.; Sandhu, S.S.; Maloh, J.; Newman, J.W.; Crawford, R.; Sivamani, R.K. Prospective Placebo-Controlled Assessment of Spore-Based Probiotic Supplementation on Sebum Production, Skin Barrier Function, and Acne. J. Clin. Med. 2023, 12, 895.
https://doi.org/10.3390/jcm12030895